Ubrelvy 100 MG tablet UD 16S
Ended Awarded
- Contract number
- SPE2DB25FBGMJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,110
Award facts
- Contract value 100% obligated
- $66,109.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $66,109.90 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging (16 count). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 22, 2025. The award was processed on September 19, 2025, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania location. UBRELVY is a calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine and represents a specialized pharmaceutical product within the Defense Health Agency's medical supply requirements.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive pharmaceutical supply vehicle for global military healthcare programs, enabling the company to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. No set-aside designation was applied to this award, reflecting AmerisourceBergen's competitive capability as a major pharmaceutical distributor supporting federal medical procurement needs for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FBGMJ?
SPE2DB25FBGMJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FBGMJ worth?
The government has obligated $66,110 on SPE2DB25FBGMJ.
Is contract SPE2DB25FBGMJ an order under another contract?
Yes. SPE2DB25FBGMJ is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGMJ competed?
The extent of competition for SPE2DB25FBGMJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award